ESC 365 - Anti-inflammation, PCSK9 inhibition, or both?

EAPC Premium Access

Anti-inflammation, PCSK9 inhibition, or both?

Session: Targeting inflammation in atherosclerosis: burning questions

Topic: Lipids

Speaker: Professor J. Tunon Fernandez (Madrid, ES)

Event: EuroPrevent 2019

Congress Presentation

Add to my library

About the speaker

Professor Jose Tunon Fernandez

Fundacion Jimenez Diaz University Hospital, Madrid (Spain)

4 presentations

0 follower

3 more presentations in this session

Are there hidden powers in omega-3 fatty acids?

Speaker: Professor M. Back (Stockholm, SE)

Inflammation, exercise and atrial fibrillation

Speaker: Doctor A. Elliott (Adelaide, AU)

Anti-inflammatory secondary prevention: what’s next?

Speaker: Doctor G. Caligiuri (Paris, FR)

Access the full session

Targeting inflammation in atherosclerosis: burning questions

Speakers: Professor J. Tunon Fernandez, Professor M. Back, Doctor A. Elliott, Doctor G. Caligiuri

About the event

EuroPrevent 2019

11 April - 13 April 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources